Skip to content

The safety and efficency of diffrent doses of dexmedetomidine as a rapid bolus for children: a double-blind, prospective, randomized study

The efficency and safety of different doses of dexmedetomidine as a rapid bolus for children:a double-blind,prospective and randomized study

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-17010658
Enrollment
Unknown
Registered
2017-02-17
Start date
2017-02-20
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediarteric Disease

Interventions

control group:normal saline
0.25µg/kg dexmedetomidine group:0.25µg/kg dexmedetomidine rapid infused
0.5µg/kg dexmedetomidine group:0.5µg/kg dexmedetomidine rapid infused
0.75µg/kg dexmedetomidine group:0.75µg/kg dexmedetomidine rapid infused
1µg/kg dexmedetomidine group:1µg/kg dexmedetomidine rapid infused

Sponsors

The second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
4 Years to 10 Years

Inclusion criteria

Inclusion criteria: (1) selective operation of inguinal hernia repair in children; (2) aged 4-10 years; (3) ASA I - II; (4) enter the operating room by himself without parents; (5) normal liver and kidney function; (6) no history of anesthesia medication allergy.

Exclusion criteria

Exclusion criteria: (1) allergic to dexmedetomidine, similar active ingredients or excipients; (2) G-6-PD; (3) a history of arrhythmia, bronchial and cardiovascular diseases, abnormal liver function and so on; (4) a history of use of alpha 2 receptor agonists or antagonists.

Design outcomes

Primary

MeasureTime frame
heart rate;plasma concentration;Emergence Agitation;

Secondary

MeasureTime frame
blood pressure;Respiratory frequency;Tidal volume;

Countries

China

Contacts

Public ContactFang Chen

The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University

15254896@qq.com+86 13957776300

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 23, 2026